GM Insects and Moral Blackmail
By Jack Stilgoe and Sarah Hartley,
The Guardian [UK]
| 12. 17. 2015
Untitled Document
In October this year, we were both called as witnesses to the House of Lords Science and Technology Select Committee. The committee was looking at the potential of genetically modified insects and asking, among other questions, “Is there a role for responsible innovation approaches?” From their answer, it would appear that they think not. In choosing to swallow the promise of this technology without questioning its downsides, their report represents an unsophisticated form of moral blackmail.
The Lords have been persuaded that GM insects have the ability to save countless lives. They argue that we have a ‘moral duty’ to support the technology and clear out any regulation that might slow its development, as Tim Radford reports this morning. The report is framed in terms of supporting ‘UK plc’ (Oxitec, the world’s leading GM insect company, is a spin-off from Oxford University). They are motivated by the ‘presence of a pioneering company based in the UK, and the world class research being conducted in our universities and institutes’. Their version of the public interest is thin and undemocratic...
Related Articles
By Isaac Schultz, Gizmodo | 10.18.2024
Colossal Biosciences, a company mainly known for intending to genetically engineer proxies for several iconic extinct species, announced this week that it has made major steps towards the de-extinction of the thylacine, or Tasmanian tiger.
The thylacine was a carnivorous...
By Russ Burlingame, Comicbook | 07.23.2024
Colossal Laboratories and Biosciences, a biotech company that's putting together plans to orchestrate the de-extinction for animals like the dodo and the wooly mammoth, made some waves on Reddit recently when they petitioned the United Federation of Planets -- the...
By Shelly Fan, Singularity Hub | 05.31.2024
We all know the drill for reproduction—sperm meets egg.
For the past decade, scientists have been pushing the boundaries of where the two halves come from. Thanks to induced pluripotent stem cell technology, it’s now possible to scrape skin cells...
By Alison Snyder, Axios | 06.06.2024
Gene editing's next chapter will be focused on tackling cancers and more common diseases, uncovering new details about aging and other fundamental aspects of biology and editing RNA, top scientists in the field said this week.
The big picture: ...